Disitertide

Disitertide, also known as P144, is a synthetic peptide derived from the transforming growth factor-beta (TGF-β) type III receptor. This carbohydrate compound is engineered to specifically interact with TGF-β signaling pathways, making it a valuable tool for researchers investigating cellular processes related to tissue remodeling and fibrosis. Disitertide exhibits high stability and solubility, facilitating its integration into various experimental protocols. Its unique sequence enables selective binding to target proteins, thereby modulating downstream signaling events. As a research-grade peptide, Disitertide provides a robust platform for dissecting complex biological mechanisms and elucidating the roles of TGF-β in different physiological and pathological contexts.

Fibrosis Research: In fibrosis research, Disitertide serves as a critical modulator of TGF-β-induced fibrotic responses. By inhibiting the interaction between TGF-β and its receptors, it effectively attenuates the activation of fibroblasts and the subsequent deposition of extracellular matrix components. Researchers utilize this peptide to investigate the molecular pathways underlying fibrotic diseases in organs such as the liver, lungs, and kidneys. Its application enables the dissection of signaling cascades that contribute to tissue scarring, offering insights into potential therapeutic strategies for managing fibrosis at the cellular level.

Cancer Biology: In the field of cancer biology, P144 is employed to study the role of TGF-β in tumor progression and metastasis. TGF-β is known to play a dual role in cancer, acting as both a tumor suppressor and a promoter of tumor invasion and metastasis depending on the context. By selectively blocking TGF-β signaling, Disitertide allows researchers to delineate the specific contributions of this pathway to cancer cell behavior, including proliferation, migration, and epithelial-to-mesenchymal transition. This targeted approach aids in the identification of novel molecular targets for cancer intervention and enhances the understanding of tumor microenvironment dynamics.

Tissue Engineering: In tissue engineering applications, Disitertide is utilized to modulate cellular responses during the regeneration and repair of damaged tissues. The peptide's ability to interfere with TGF-β signaling helps control the balance between tissue regeneration and fibrosis, which is crucial for the successful integration of engineered tissues. By fine-tuning the cellular environment, it supports the development of scaffolds and biomaterials that promote healthy tissue formation while minimizing the risk of excessive scarring. This makes Disitertide an important component in the advancement of regenerative medicine research.

Inflammatory Disease Models: Researchers investigating inflammatory disease models frequently use Disitertide to explore the interplay between inflammation and fibrosis. TGF-β signaling is a key mediator of immune responses and tissue remodeling during chronic inflammation. By modulating this pathway, the peptide provides a means to study the mechanisms by which inflammation leads to fibrotic changes in various tissues. Such studies are instrumental in identifying new molecular targets for controlling inflammation-induced tissue damage and in developing strategies to prevent or reverse pathological fibrosis.

Nephrology Research: In nephrology research, Disitertide is applied to examine the mechanisms of renal fibrosis and glomerulosclerosis. Its selective inhibition of TGF-β signaling allows for a detailed analysis of the cellular and molecular events that drive kidney tissue remodeling. By using this peptide in in vitro and in vivo models, scientists can better understand the progression of chronic kidney diseases and identify potential interventions to halt or slow down fibrotic processes. The insights gained from these studies contribute to the broader knowledge base of renal pathophysiology and support the development of innovative research tools for kidney disease.

Collectively, Disitertide's versatility and specificity make it a valuable asset across multiple research domains, including fibrosis, oncology, tissue engineering, inflammation, and nephrology. Its targeted mechanism of action provides researchers with a precise tool for unraveling the complexities of TGF-β signaling and its impact on diverse cellular processes. As scientific investigations continue to uncover the multifaceted roles of TGF-β in health and disease, the applications of Disitertide are poised to expand, driving forward progress in both basic and applied biomedical research.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. TMEM16F and dynamins control expansive plasma membrane reservoirs